Skip to main content

Ranjit Kumar Chandra has been stripped of his membership in the Order of Canada.

EFE

Ranjit Kumar Chandra, a former researcher at Memorial University in St. John's who has been accused of scientific fraud, has been stripped of his membership in the Order of Canada.

Chandra was made an officer of the order, the second-highest level in the honour system, in December 1989.

The announcement of the loss of his status was published in this week's Canada Gazette, although the order was made in early December.

Story continues below advertisement

Last fall, the BMJ – formerly the British Medical Journal – retracted a 1989 Chandra paper about the role of breastfeeding and formula in infant eczema after the data involved was questioned.

The journal called the case a major failure of scientific governance.

In July 2015, Chandra lost a libel suit against the CBC over a 2006 three-part documentary that examined allegations of fraud against the researcher.

The CBC says Chandra was ordered to pay $1.6-million in costs.

Chandra once called himself "the father of nutritional immunology," but his career began to unravel in 2002 when he submitted another paper to the BMJ, which questioned some of the research.

He left Memorial that year.

His website says he's now president of the Nutritional Immunology and Allergy Center in India.

Story continues below advertisement

He is also listed as chairman and managing director of Peridot Life Sciences, of Gurgaon, India, which calls itself a research-based pharmaceutical company that specializes in the field of nutritional immunology.

Removal from the Order of Canada has only happened in a handful of cases since the honour was established in 1967, usually as a result of criminal convictions.

Those stripped of membership include disgraced lawyer and hockey agent Alan Eagleson, theatre producer Garth Drabinsky, former newspaper baron Conrad Black and cross-country amputee runner Steve Fonyo.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter